Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01681095Phase 2Completed
A Phase 2 trial of Custodiol HTK Solution in coronary artery disease (CAD), valvular heart disease (VHD). Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01681095.